“showed a trend”

In the age group 80 to 90, the underweight showed a trend of increased mortality compared to the normal weight, without reaching statistical significance ( p < 0.05).

Primary tumour MTV and TLG at baseline showed a trend towards poor treatment response and death. ΔNodal parameters all statistically correlated with primary TR (p < 0.05).

Although there was no notable disparity in the levels of HDL‐C between the two groups, the levels of TC and LDL‐C in the SA group showed a trend of increase compared to the NSA group, with certain time points showing significant differences (TC, at the fourth to eighth month, p < 0.05; LDL‐C, at the fourth, fifth, and eighth month, p < 0.05).

Although the mice treated with VV-α-TIGIT only showed a trend of lower tumor volume compare to mice treated with VV-Control ( P > 0.05) ( Fig. 5 F ), these mice demonstrated a significantly longer survival time than mice treated with VV-Control ( P <0.01) ( Fig. 5 G ).

Infantis showed a trend characterized by a high APC from 2008–2010 (p < 0.05) followed by a lower APC from 2010–2018 (p > 0.05) (see Suppl.

genes that were ranked by correlation coefficient for the delta change in glycemia at 2h and change in gene expression at the same time showed a trend towards enrichment of the Hallmark geneset for glycolysis ( p = 0.05).

Vessel segments in the corpus callosum also showed a trend towards higher tortuosity compared to the other regions (corpus callosum; 1.16 ± 0.03 vs. cortex; 1.13 ± 0.02 and basal ganglia; 1.14 ± 0.01, p > 0.05).

The PFS of patients presenting with pancreatic metastases on sunitinib showed a trend toward being significantly higher than for those without pancreatic metastases (HR, 0.52; 95% CI, 0.27–1.01; P = 0.05).

While E2 levels in the Ctr-T group showed a trend toward lower levels than the Sham group, this difference was not statistically significant ( P > 0.05).

Patients with less than 5 bone metastases showed a trend favoring RT (HR 0.68, P>0.05) ( 50 ).

Compared to Sham, L-VNS and Rapa alone showed a trend toward increased Treg infiltration; L-VNS combined with Rapa induced more Treg infiltration by 42.76% ( p < 0.05; Figures 7 A and 7B).

The puppies in the treatment group showed a trend of reduced fat gain compared with those in the control group, and with a marginally significant difference at 6 months ( P = 0·05).

Spotty calcification showed a trend towards higher prevalence in vulnerable plaques (59% vs. 23%; P=0.05).

All patients showed a trend to lower blood pressure, SVR, and inotropy (P<0.05), but HR, SV, and CO returned to baseline values after 6 weeks treatment (P>0.05).

Transport/geographic barriers showed a trend toward being more common in LMIC studies ( p = 0.05).

Those who had reported more difficulty in attending 'suitable' courses showed a trend significant at the p < 0.05 level for less confidence in arthroscopy and sports medicine.

Survival analysis indicated that high LINC00852 expression also showed a trend towards poor survival (P > 0.05) ( Figure 1 F ).

But the gene set enrichment analysis performed on the summary statistics of the polygenic risk score (PRS) computed with 6.7 million SNPs spread over the whole genome (pathway-based polygenic risk score analysis) derived from the multi-ancestry BD sample identified several genetic pathways containing purinergic receptor genes that showed a trend of association with BD ( P -values close to GWAS significance ( P = 0.05 _8 ).

In the airway analysis, the volume increased by 6.2% ( p = 0.327), while the area showed a trend toward improvement (20%; p = 0.050), approaching statistical significance.

Moreover, age, BMI, and TyG index showed a trend of gradually increasing CVD risk in patients with pSjD ( P < 0.05).

The effect size for the multiple sclerosis subgroup showed a trend in favor of eHealth interventions (SMD –0.47, 95% CI –0.95 to 0.01, P =.05, I2=63.10%), but was not significant for the cancer group (SMD 0.61, 95% CI –0.36 to 1.58, P =.22).

Age had a significant level of correlation with walking program adherence ( n = 8, r = 0.72, p = 0.019), and it showed a trend with exercise program adherence ( n = 7, r = 0.60, p = 0.05).

Fasting plasma glucose levels between weeks 0 and 12 decreased similarly in control group ( P < 0.05) and vildagliptin group ( P < 0.05); HbA1c levels showed a trend to decrease in both groups ( P < 0.05).

Semiquantitative WB analysis showed a trend to increase in TOM20/actin ratio ( P = 0.05), which suggests an increase in mitochondrial number or mitochondrial dimensions in YS compared to WT fibers of FDB muscles ( Figure 4A ).

In the TCGA cohort, Treg levels in HER2-high tumors showed a trend of maintenance or relative enrichment across all thresholds, reaching statistical significance at the 20% and 30% cutoffs ( P < 0.05; Fig. 7 B–C), whereas the 10% threshold only showed a non-significant trend (Fig. 7 A).